Richard Frank, MD, MHSA, Chief Medical Officer at Vida Health, spoke to Medical News Today about how orforglipron may expand access to GLP-1s: The choice between a pill and an injectable comes down to patient preference and potency. The injectables are clearly more potent but require a weekly injection
And the introduction of oral drugs this year has been a big topic
This spacing gives your medication time to begin working in your system before introducing a stimulus that might increase gastric irritation
Best Peptides for Hemorrhoids Research & Mechanisms Research from institutions including Tokyo Medical University has identified specific peptide sequences that modulate the exact biological pathways compromised in hemorrhoidal tissue
Hypocaloric diet, maintained training
When assessing WL post-bariatric surgery and WR thereafter before initiation of therapy, our analysis found no significant differences between the GLP-1RAs and placebo groups, with (SMD = 0.23, 95% CI 0.36 to 0.81) for WL and SMD = 0.33, 95% CI 0.11 to 0.77) for WR, respectively (Supplementary Figs
